We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-9.86%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$16.1B
AUM Growth
-$2.79B
(-15%)
Cap. Flow
-$319M
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
844
New
146
Increased
323
Reduced
295
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Valero Energy
VLO
|
+$111M |
| 2 |
Kinder Morgan
KMI
|
+$108M |
| 3 |
WLL
Whiting Petroleum Corporation
WLL
|
+$101M |
| 4 |
IAMGOLD
IAG
|
+$80.8M |
| 5 |
Hecla Mining
HL
|
+$78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$221M |
| 2 |
B
Barrick Mining
B
|
+$188M |
| 3 |
Newmont
NEM
|
+$130M |
| 4 |
ANDV
Andeavor
ANDV
|
+$118M |
| 5 |
Franco-Nevada
FNV
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 43.59% |
| 2 | Energy | 24.2% |
| 3 | Healthcare | 6.87% |
| 4 | Industrials | 4.15% |
| 5 | Technology | 3.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESV
101
DELISTED
Ensco Rowan plc
ESV
| $42.1M | 0.26% |
351,572
+59,730
| +20% | +$8.56M |
|
102
Tenaris
TS
$29.1B
| $38.9M | 0.24% |
1,288,034
+123,320
| +11% | +$4.41M |
|
103
Fortuna Silver Mines
FSM
$2.59B
| $38.6M | 0.24% |
8,486,637
-5,498,822
| -39% | -$23.6M |
|
104
Helmerich & Payne
HP
$3.53B
| $38.2M | 0.24% |
566,711
+59,559
| +12% | +$4.64M |
|
|
BTU
105
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $37.5M | 0.23% |
323,191
-13,319
| -4% | -$1.99M |
|
106
Tractor Supply
TSCO
$16.3B
| $36.6M | 0.23% |
2,322,410
-630,030
| -21% | -$9.03M |
|
|
WFT
107
DELISTED
Weatherford International plc
WFT
| $36.5M | 0.23% |
3,189,099
+726,515
| +30% | +$10.9M |
|
|
MAG
108
DELISTED
MAG Silver
MAG
| $33.2M | 0.21% |
4,050,986
-3,360,956
| -45% | -$24M |
|
|
ALXN
109
DELISTED
Alexion Pharmaceuticals
ALXN
| $31M | 0.19% |
167,685
+3,306
| +2% | +$613K |
|
110
Advanced Drainage Systems
WMS
$10.9B
| $30.5M | 0.19% |
+1,328,100
| New | +$29M |
|
111
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $30.4M | 0.19% |
213,546
+47,077
| +28% | +$6.37M |
|
112
Johnson & Johnson
JNJ
$635B
| $30.3M | 0.19% |
290,078
-130,125
| -31% | -$13.7M |
|
113
Transocean
RIG
$5.92B
| $30.3M | 0.19% |
1,651,766
+135,323
| +9% | +$3.38M |
|
114
Oceaneering
OII
$5.25B
| $30M | 0.19% |
510,443
-8,451
| -2% | -$543K |
|
115
CSX Corp
CSX
$98.6B
| $29.7M | 0.18% |
+2,462,100
| New | +$28.8M |
|
116
Vertex Pharmaceuticals
VRTX
$121B
| $29.3M | 0.18% |
246,683
-11,988
| -5% | -$1.35M |
|
117
Novartis
NVS
$295B
| $29.3M | 0.18% |
352,597
-127,714
| -27% | -$10.6M |
|
118
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
| $29.2M | 0.18% |
+252,496
| New | +$30M |
|
119
Union Pacific
UNP
$183B
| $29.2M | 0.18% |
+244,946
| New | +$28.1M |
|
|
RBY
120
DELISTED
RUBICON MENERALS CORP (F)
RBY
| $29.1M | 0.18% |
29,856,452
-22,029,168
| -42% | -$23M |
|
121
Illumina
ILMN
$29.4B
| $29M | 0.18% |
161,374
+19,954
| +14% | +$3.52M |
|
122
BioMarin Pharmaceuticals
BMRN
$11.5B
| $28.5M | 0.18% |
315,733
+43,571
| +16% | +$3.62M |
|
123
Regeneron Pharmaceuticals
REGN
$68.8B
| $28M | 0.17% |
68,332
-833
| -1% | -$328K |
|
|
DRC
124
DELISTED
DRESSER-RAND GROUP INC
DRC
| $27.9M | 0.17% |
341,050
+69,102
| +25% | +$5.62M |
|
|
PE
125
DELISTED
PARSLEY ENERGY INC
PE
| $27.7M | 0.17% |
1,732,800
-2,400
| -0.1% | -$38.9K |
|
Similar funds
DAM
VanEck Associates's Q4 2014 Portfolio in Review
As of Q4 2014, VanEck Associates held 844 positions worth $16.1B, down 15% from $18.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
VanEck Associates's Q4 2014 filing shows 146 new, 323 increased, 295 reduced and 69 closed positions. Its largest new stake was Allergan plc: 238,299 shares worth $61.3M. The largest sale was Goldcorp Inc, an estimated $221M.
By sector, the portfolio is most concentrated in Materials at 44% of assets, down from 45% a quarter earlier, followed by Energy and Healthcare.
- VanEck Associates's largest Q4 2014 buy was Allergan plc: 238,299 shares worth $61.3M.
- VanEck Associates added most to Valero Energy in Q4 2014, an estimated $111M increase.
- VanEck Associates's biggest Q4 2014 reduction was Goldcorp Inc, cutting an estimated $221M.
- VanEck Associates fully exited Atwood Oceanics in Q4 2014, selling an estimated $101M.
- VanEck Associates's ten largest holdings make up 26% of its $16.1B portfolio in Q4 2014.
- VanEck Associates opened 146 new positions and closed 69 in Q4 2014.
- VanEck Associates's portfolio value fell 15% quarter-over-quarter to $16.1B.
Based on VanEck Associates's 13F filing for Q4 2014, filed 13 Feb 2015.